Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cerulea Clinical Trials is newly established as a state-of-the-art ophthalmic clinical trial center in Melbourne. It delivers both investigator-led and industry-sponsored studies across all phases of development. The center specializes in advanced therapeutics such as gene and cell therapies for vision loss and blindness. Early results include the launch of new gene therapy trials for inherited retinal diseases like retinitis pigmentosa and Stargardt’s disease; however, specific efficacy or outcome data are not yet available due to the recent opening of the facility.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cerulea Clinical Trials.